Vessi Medical is developing a new approach in the treatment of non-muscle invasive bladder cancer (NMIBC).

The company treats superficial bladder cancer using surface cryotherapy, a treatment that utilizes extreme cold to freeze and destroy abnormal tissue.

The Vessi Medical system consists of a stand-alone console and a disposable catheter which is inserted into the bladder in a manner similar to existing intravesical techniques.

Vessis minimally invasive bladder-specific cryotherapy solution for NMIBC provides a therapeutic alternative to surgery while reducing the cost and eliminating the complications associated with TURBT.First in human study (FIH) clinical trials initiated 2021.